Schweizerischer Nationalfonds / Fonds national suisse
Aktuelle Storys zum Coronavirus
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Schweizerischer Nationalfonds / Fonds national suisse
Brain scans of people with MS help us understand the effects of Covid
Bern (ots) - People affected by multiple sclerosis need to undergo regular MRI brain scans. The images are now being used to visualise the effects of a coronavirus infection. Brain fog, memory problems, loss of the sense of smell - Covid-19 affects the brain in a number of ways, yet the mechanisms behind this remain largely unknown. This is because disease-related changes in our brains are almost impossible to detect if ...
mehrLargest decentralised study of its kind shows high levels of engagement with Huma's study app
London (ots/PRNewswire) - - More than 90% of 2,524 participants invited to join a fully virtual COVID-19 study, run by Cambridge researchers, downloaded and registered on the study app1 - Around 75% of participants completed digital biomarker assessments such as resting heart rate, temperature and oxygen saturation at least once per week1 - Participants were aged 45 - ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Improving the efficacy of antibiotics and curbing resistance
Bern (ots) - New findings from NRP 72, financed by the Swiss National Science Foundation, are helping to curb antibiotic resistance. In the field of new antibiotics, however, structures needed for translating results into practice are lacking. Worldwide, more and more pathogens are becoming resistant to today's antibiotics. As antibiotics lose their efficacy, infections that were once easy to treat can give rise to fatal ...
mehrForging a healthier future through research: McGill University launches new Institute of Genomic Medicine
Montreal (ots/PRNewswire) - Landmark donation from alumnus Dr. Victor Phillip Dahdaleh will accelerate advances in global health using genomic medicine to inform patient diagnosis and care A landmark donation to support McGill University's renowned genomics research and education programs from UK-based alumnus and ...
mehrPharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib
Leiden, Netherlands (ots/PRNewswire) - Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency This submission follows the grant of accelerated assessment allowing an expedited review for leniolisib from a standard 210 days ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Broad-based Swiss Covid-19 research
Bern (ots) - During the coronavirus pandemic, the Swiss National Science Foundation (SNSF) supported a total of 114 Covid-19 research projects, for which it used funding of over CHF 45 million. In the National Research Programme "Covid-19" (NRP 78), around 200 researchers are working in 28 projects with a total budget of CHF 20 million. Another research programme on Covid-19 is about to start. It was the first time the ...
mehrInfosys: Industry leading revenue growth in Q1 lays robust foundation for the year
Bengaluru, India (ots/PRNewswire) - - FY 23 Revenue guidance increased to 14%-16%. - Margin guidance retained at 21%-23% Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered a robust performance in Q1 with year-on-year growth at 21.4% and sequential growth at 5.5% in constant currency. Year on year ...
mehrUK MEDTECH COMPANY TO HELP PROTECT US HEALTHCARE WORKERS AND US CITIZENS FROM 1 MILLON NEEDLESTICK INJURIES EACH YEAR
Liverpool England and Philadelphia USA (ots) - --News Direct-- SAFETY INITIATIVE AND COMPLIANCE WILL SAVE AMERICAN HEALTHCARE INDUSTRY $1 BILLION British smart MedTech company NeedleSmart, which is pioneering disruptive technologies in the global healthcare sector, is expanding into the US healthcare market to ...
mehrNanoPass's intradermal injection platform proven to sustain COVID-19 vaccine antibodies using 1/15 of the dose reports Chinese Institute of Medical Biology
Nes Ziona, Israel and Shanghai, China (ots/PRNewswire) - Intradermal COVID vaccination studies are emerging in a global effort to multiply available doses by harnessing skin immunity to reduce dosage required for effective vaccination. In a hallmark study published recently by IMB scientists[1], subjects were ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Animal experiments and 3R: Immune cells live in a complex world
Bern (ots) - Some research relies almost entirely on animal models. An example is the SNSF-funded project on virus surveillance in the mouse brain. "The immune system has a place where it is born, a place where it is educated and a place where it goes to work." Natalia Pikor, research group leader at St. Gallen cantonal hospital, is studying one of the most complicated systems in the bodies of vertebrate animals and ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Wastewater provides new insight into Covid-19 dynamics
Bern (ots) - An interdisciplinary team funded by the Swiss National Science Foundation shows that the R number of coronavirus can be estimated quickly and cost-effectively from wastewater. Since the start of the coronavirus (Sars-Cov-2) pandemic, many public health measures have been decided based on its dynamic of spread, more precisely, on the reproductive number of the virus, known as the R number. This value indicates ...
mehr- 2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
mehr Wegovy(TM) Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity
Bagsværd, Denmark (ots/PRNewswire) - - The STEP 5 trial demonstrated an average weight loss of 15.2% with Wegovy(TM) at 104-weeks when used with a reduced calorie meal plan and increased physical activity vs. 2.6% with placebo - The trial also showed that 77.1% of study participants who received Wegovy(TM) lost at ...
mehrTNO research shows effectiveness of corona cannon
Rijswijk, Netherlands (ots/PRNewswire) - Addition due to incomplete information in the press release as sent on 4 June 2021 Analyses carried out by TNO in a BSL-3 laboratory cabinet showed that the corona gun had achieved a 94.9% reduction in the Covid -19 virus after 15 minutes. In the laboratory set-up, the (live) virus was located on stainless steel plates at 85 cm from the device. Earlier, the Dutch scientific ...
mehrForaCare Suisse AG releases Rapid COVID-19 Antigen Test / Test Results in 15 Minutes, No Laboratory Processing Required, Highly Accurate & Reliable Results
ST. GALLEN, Switzerland (ots) - ForaCare Suisse AG announced the release of its antigen test, FORA COVID-19 Antigen Rapid Test, that provides fast, accurate and easy-to-interpret test results. The test can be administered by trained professionals and doesn’t rely on laboratory-processing. Approved by Swissmedic, ...
mehrSwiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
mehrSchweizerischer Nationalfonds / Fonds national suisse
Meeting challenges through basic research
Bern (ots) - Many scientists are currently undertaking work on the Sars-CoV-2 virus. But hundreds of projects supported by the SNSF are already contributing to finding answers to the current health crisis. In Switzerland and around the world, the novel coronavirus has become a priority for scientific research. Projects supported by the Swiss National Science Foundation (SNSF) are no exception. A special call and a ...
mehrNEOVII Partners with Tel Aviv University to Develop Novel COVID-19 Vaccine
Rapperswil, Switzerland and Tel Aviv, Israel (ots/PRNewswire) - The epitope-based vaccine will target the most vulnerable part of the viral spike protein Ramot , Tel Aviv University's technology transfer company, and Neovii , a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license ...
mehrNEOVII to Develop a Novel Vaccine for COVID-19 in an Exclusive Partnership With Tel Aviv University
Rapperswil, Switzerland (ots/PRNewswire) - Neovii, the Swiss-based biopharmaceutical company and a member of Israeli-based Neopharm Group, has signed a research and license agreement with Tel Aviv University's (TAU) RAMOT, its technology transfer company, to work in collaboration with a team led by Professor ...
mehr